IT1398032B1 - Transferrina per il trattamento di malattie autoimmuni. - Google Patents

Transferrina per il trattamento di malattie autoimmuni.

Info

Publication number: IT1398032B1
Authority: IT; Italy
Prior art keywords: transferrina; treatment; autoimmune diseases; autoimmune; diseases
Prior art date: 2010-02-15

Application number

ITFI2010A000020A

Other languages

English (en)

Inventor

Filippo Mori

Ester Ascione

Ferdinando Nicoletti

Pierangelo Giovacchini

Original Assignee

Kedrion Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-02-15

Filing date

2010-02-15

Publication date

2013-02-07

2010-02-15 Application filed by Kedrion Spa filed Critical Kedrion Spa

2010-02-15 Priority to ITFI2010A000020A priority Critical patent/IT1398032B1/it

2011-02-15 Priority to EP11711655.8A priority patent/EP2536419B1/en

2011-02-15 Priority to ES11711655.8T priority patent/ES2674326T3/es

2011-02-15 Priority to HUE11711655A priority patent/HUE038120T2/hu

2011-02-15 Priority to CA2787727A priority patent/CA2787727C/en

2011-02-15 Priority to PCT/IB2011/050623 priority patent/WO2011098990A1/en

2011-02-15 Priority to US13/574,646 priority patent/US9138454B2/en

2011-08-16 Publication of ITFI20100020A1 publication Critical patent/ITFI20100020A1/it

2013-02-07 Application granted granted Critical

2013-02-07 Publication of IT1398032B1 publication Critical patent/IT1398032B1/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Hematology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Transplantation (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ITFI2010A000020A 2010-02-15 2010-02-15 Transferrina per il trattamento di malattie autoimmuni. IT1398032B1 (it)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
ITFI2010A000020A IT1398032B1 (it)	2010-02-15	2010-02-15	Transferrina per il trattamento di malattie autoimmuni.
EP11711655.8A EP2536419B1 (en)	2010-02-15	2011-02-15	Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
ES11711655.8T ES2674326T3 (es)	2010-02-15	2011-02-15	Transferrina para su uso en el tratamiento y/o profilaxis de enfermedades autoinmunes
HUE11711655A HUE038120T2 (hu)	2010-02-15	2011-02-15	Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra
CA2787727A CA2787727C (en)	2010-02-15	2011-02-15	Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
PCT/IB2011/050623 WO2011098990A1 (en)	2010-02-15	2011-02-15	Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
US13/574,646 US9138454B2 (en)	2010-02-15	2011-02-15	Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITFI2010A000020A IT1398032B1 (it)	2010-02-15	2010-02-15	Transferrina per il trattamento di malattie autoimmuni.

Publications (2)

Publication Number	Publication Date
ITFI20100020A1 ITFI20100020A1 (it)	2011-08-16
IT1398032B1 true IT1398032B1 (it)	2013-02-07

Family

ID=42542741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ITFI2010A000020A IT1398032B1 (it)	2010-02-15	2010-02-15	Transferrina per il trattamento di malattie autoimmuni.

Country Status (7)

Country	Link
US (1)	US9138454B2 (it)
EP (1)	EP2536419B1 (it)
CA (1)	CA2787727C (it)
ES (1)	ES2674326T3 (it)
HU (1)	HUE038120T2 (it)
IT (1)	IT1398032B1 (it)
WO (1)	WO2011098990A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9534029B2 (en)	2012-10-03	2017-01-03	Csl Behring Ag	Method of purifying proteins
EP3318256A1 (en)	2016-11-08	2018-05-09	Quimatryx, S.L	Compounds for the treatment of autoimmune diseases
JP2025000300A (ja) *	2023-06-19	2025-01-07	国立大学法人神戸大学	アデノシン三リン酸の捕捉剤及びアデノシン二リン酸の捕捉剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0696455A1 (en)	1994-08-11	1996-02-14	Cellena (Cell Engineering) A.G.	Transferrin compositions to alleviate the side effects of cytotoxic drugs
DE69527640T2 (de)	1994-11-10	2003-04-24	Cellena Ag, Ebmatingen	Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
US5849293A (en) *	1996-01-11	1998-12-15	Cornell Research Foundation, Inc.	Use of human transferrin in controlling insulin levels
US6126955A (en)	1998-04-16	2000-10-03	University Of Utah Research Foundation	Apo-transferrin as a potent inhibitor of bacterial adhesion to biomaterials
US6326473B1 (en) *	1998-12-30	2001-12-04	Suomen Punainen Risti Veripalvelu	Pharmaceutical preparations
DE10215315A1 (de) *	2002-04-05	2003-11-20	Aventis Behring Gmbh Intellect	Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
WO2007076505A2 (en) *	2005-12-28	2007-07-05	Essential Skincare, Llc	Transferrin and transferrin-based compositions for diabetes treatment
ITLU20070009A1 (it)	2007-05-21	2008-11-22	Kedrion Spa	Uso di transferrina per la preparazione di composizioni farmaceutiche utili per il trattamento di infezioni batteriche come coadiuvanti nella terapia antibiotica.
CA2732764C (en) *	2008-03-11	2023-04-04	Livionex Inc.	Methods and compositions for treating inflammation and inflammation-related pathologies

2010
- 2010-02-15 IT ITFI2010A000020A patent/IT1398032B1/it active
2011
- 2011-02-15 ES ES11711655.8T patent/ES2674326T3/es active Active
- 2011-02-15 EP EP11711655.8A patent/EP2536419B1/en active Active
- 2011-02-15 HU HUE11711655A patent/HUE038120T2/hu unknown
- 2011-02-15 CA CA2787727A patent/CA2787727C/en active Active
- 2011-02-15 US US13/574,646 patent/US9138454B2/en active Active
- 2011-02-15 WO PCT/IB2011/050623 patent/WO2011098990A1/en not_active Ceased

Also Published As

Publication number	Publication date
HUE038120T2 (hu)	2018-09-28
US9138454B2 (en)	2015-09-22
US20120296071A1 (en)	2012-11-22
ES2674326T3 (es)	2018-06-28
WO2011098990A1 (en)	2011-08-18
CA2787727A1 (en)	2011-08-18
EP2536419B1 (en)	2018-04-04
EP2536419A1 (en)	2012-12-26
ITFI20100020A1 (it)	2011-08-16
CA2787727C (en)	2018-08-21

Publication	Publication Date	Title
LTC2785706I2 (lt)	2023-07-10	Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
HUS1900007I1 (hu)	2019-04-29	Kiméra, antigénreceptor-módosított T-sejt alkalmazása rák kezelésére
SMT201700021B (it)	2017-03-08	Metodi per il trattamento di malattie autoimmuni con antagonisti del dll4
SMT201600064B (it)	2016-04-29	Anticorpi per il trattamento di un cancro esprimente claudina 6
LT2558105T (lt)	2020-02-10	Bardoksolono metilas, skirtas nutukimo gydymui
IT1401188B1 (it)	2013-07-12	Dispositivo medico per patologie colonproctologiche.
EP2595532A4 (en)	2014-04-09	IMPLANTABLE DIELECTROMETER
LT3023102T (lt)	2018-09-25	Ibat inhibitoriai, skirti kepenų ligų gydymui
EP2680775A4 (en)	2014-10-01	Cryogenic medical system
EP2433335A4 (en)	2013-05-01	Connector
DK3124610T3 (da)	2019-06-11	Hbv-behandling
DK2627345T3 (da)	2014-09-01	Formuleringer til behandling af sygdomme i de øvre luftveje
SMT201500142B (it)	2015-09-07	Procedimento per la purificazione di proteine
PL2582366T3 (pl)	2016-04-29	Kombinacja farmaceutyczna do leczenia bólu
EP2613409A4 (en)	2014-01-15	Connector
IT1404454B1 (it)	2013-11-22	Procedimento per la realizzazione di sbozzati per scatole su misura.
LT2782602T (lt)	2019-10-10	Nukleotidas dims0-150, skirtas lėtinio aktyvaus opinio kolito gydymui
EP2520216A4 (en)	2013-02-27	Endoscope system
EP2584655A4 (en)	2014-12-31	CONNECTOR
EP2578161A4 (en)	2013-04-10	ULTRASOUND DEVICE
DK2590565T3 (da)	2014-08-25	Blodprøvetagning
ITRM20120473A1 (it)	2014-04-05	Use of glycerophosphoinositols for the treatment of septic shock
ITRM20120530A1 (it)	2014-05-01	Compounds for use in the treatment of parasitic diseases
DK2455064T3 (da)	2021-02-22	Indretning til behandling af periodontal sygdom
ITTO20110857A1 (it)	2012-03-28	Procedimento per la produzione di cicloesanonossina.